Resistance to Bensulfuron-Methyl in Water Plantain (Alisma plantago-aquatica) Populations from Chilean Paddy Fields

2008 ◽  
Vol 22 (4) ◽  
pp. 602-608 ◽  
Author(s):  
Rodrigo Figueroa ◽  
Marlene Gebauer ◽  
Albert Fischer ◽  
Marcelo Kogan
Keyword(s):  
Weed Management ◽  
Wide Spectrum ◽  
Acetolactate Synthase ◽  
Rice Fields ◽  
Integrated Weed Management ◽  
Cross Resistance ◽  
Content Type ◽  
Als Inhibitors

Bensulfuron-methyl (BSM) has been one of the most widely used herbicides in Chilean rice fields because it controls a wide spectrum of weeds and does not require field drainage for application. However, failures of BSM to control water plantain in rice fields have been noted since 2002. We assessed BSM effects on suspected resistant (CU1 and CU2) and susceptible (AN1) water plantain accessions collected in Chilean rice fields during 2004 and 2005. BSM rates resulting in 50% growth reduction (GR50) of CU2 and CU1 plants were 12- and 33-fold higher than for AN1 plants, respectively. Acetolactate synthase (ALS) activity assays in vitro suggested resistance in CU1 and CU2 was due to an ALS enzyme with reduced BSM sensitivity compared to the AN1 biotype. Resistance indices (RI), or ratios of the resistant to susceptibleI50values (BSM rate to inhibit ALS-enzyme activity by 50%), were 266 (CU2/AN1) and > 38,462 (CU1/AN1). This agreed with in vivo ALS activity assays whereRIwere 224 (CU2/AN1) and > 8,533 (CU1/AN1). Resistance levels detected in whole-plant or in vivo ALS activity assays were orders of magnitude lower than those detected in in vitro ALS activity studies suggesting nontarget site mechanisms may have mitigated BSM toxicity. However, a consistent ranking of BSM sensitivity levels (AN1 > CU2 > CU1) throughout all three types of assays suggests resistance is primarily endowed by low target site sensitivity. We conclude that susceptible and resistant water plantain biotypes coexist in Chilean paddies, and the use of integrated weed management involving herbicides with a different mode of action would be imperative to prevent further evolution of resistance to BSM and possibly cross-resistance to other ALS inhibitors. In vitro ALS-enzyme assays provided the best discrimination of resistance levels between biotypes.

scholarly journals In VitroandIn VivoActivity of Solithromycin (CEM-101) against Plasmodium Species

2011 ◽  
Vol 56 (2) ◽  
pp. 703-707 ◽  
Author(s):  
Sergio Wittlin ◽  
Eric Ekland ◽  
J Carl Craft ◽  
Julie Lotharius ◽  
Ian Bathurst ◽  
...  
Keyword(s):  
Drug Exposure ◽  
Antimalarial Activity ◽  
Plasmodium Species ◽  
Parasite Clearance ◽  
Response To Treatment ◽  
Cross Resistance ◽  
Asexual Blood Stage ◽  
Content Type

ABSTRACTWith the emergence ofPlasmodium falciparuminfections exhibiting increased parasite clearance times in response to treatment with artemisinin-based combination therapies, the need for new therapeutic agents is urgent. Solithromycin, a potent new fluoroketolide currently in development, has been shown to be an effective, broad-spectrum antimicrobial agent. Malarial parasites possess an unusual organelle, termed the apicoplast, which carries a cryptic genome of prokaryotic origin that encodes its own translation and transcription machinery. Given the similarity of apicoplast and bacterial ribosomes, we have examined solithromycin for antimalarial activity. Other antibiotics known to target the apicoplast, such as the macrolide azithromycin, demonstrate a delayed-death effect, whereby treated asexual blood-stage parasites die in the second generation of drug exposure. Solithromycin demonstrated potentin vitroactivity against the NF54 strain ofP. falciparum, as well as against two multidrug-resistant strains, Dd2 and 7G8. The dramatic increase in potency observed after two generations of exposure suggests that it targets the apicoplast. Solithromycin also retained potency against azithromycin-resistant parasites derived from Dd2 and 7G8, although these lines did demonstrate a degree of cross-resistance. In anin vivomodel ofP. bergheiinfection in mice, solithromycin demonstrated a 100% cure rate when administered as a dosage regimen of four doses of 100 mg/kg of body weight, the same dose required for artesunate or chloroquine to achieve 100% cure rates in this rodent malaria model. These promisingin vitroandin vivodata support further investigations into the development of solithromycin as an antimalarial agent.

In vitro and whole-plant magnitude and cross-resistance characterization of two imidazolinone-resistant sugarbeet (Beta vulgaris) somatic cell selections

Weed Science ◽  
1998 ◽  
Vol 46 (1) ◽  
pp. 24-29 ◽  
Author(s):  
Terry R. Wright ◽  
Donald Penner
Keyword(s):  
Somatic Cell ◽  
Shoot Culture ◽  
Acetolactate Synthase ◽  
Cross Resistance ◽  
Shoot Cultures ◽  
Als Inhibitors ◽  
Whole Plants ◽  
Inhibitor Resistance ◽  
Als Inhibitor

Acetolactate synthase (ALS)-inhibiting herbicide carryover in soil can severely affect sugarbeets grown in the year(s) following application. Two newly developed imidazolinone-resistant (IMI-R) sugarbeet somatic cell selections (Sir-13 and 93R30B) were examined for magnitude of resistance and extent of cross-resistance to other classes of ALS inhibitors and compared to a previously developed sulfonylurea-resistant (SU-R) selection, Sur. In vitro shoot culture tests indicated Sir-13 resistance was specific to imidazolinone (IMI) herbicides at approximately a 100-fold resistance compared to the sensitive control sugarbeet. Sur was 10,000-fold resistant to the sulfonylurea (SU) herbicide, chlorsulfuron, and 40-fold resistant to the triazolopyrimidine sulfonanilide (TP) herbicide, flumetsulam, but not cross-resistant to the IMI herbicides. 93R30B was selected for IMI-R from a plant homozygous for the SU-R allele,Sur, and displayed similar in vitro SU-R and TP-R as Sur, but also displayed a very high resistance to various IMI herbicides (400- to 3,600-fold). Compared to the sensitive control, Sir-13 was 300- and > 250-fold more resistant to imazethapyr and imazamox residues in soil, respectively. Response by whole plants to postemergence herbicide applications was similar to that observed in shoot cultures. Sir-13 exhibited > 100-fold resistance to imazethapyr as well as imazamox, and 93R30B showed > 250-fold resistance to both herbicides. 93R30B showed great enough resistance to imazamox to merit consideration of imazamox for use as a herbicide in these sugarbeets. Sir-13 showed a two- to threefold higher level of resistance in the homozygous vs. heterozygous state, indicating that like most ALS-inhibitor resistance traits, it was semidominantly inherited.

Target site–based penoxsulam resistance in barnyardgrass (Echinochloa crus-galli) from China

Weed Science ◽  
2019 ◽  
Vol 67 (3) ◽  
pp. 281-287 ◽  
Author(s):  
Jiapeng Fang ◽  
Tingting Liu ◽  
Yuhua Zhang ◽  
Jun Li ◽  
Liyao Dong
Keyword(s):  
Amino Acid ◽  
Amino Acid Sequence ◽  
Acetolactate Synthase ◽  
Target Site ◽  
Cross Resistance ◽  
Predicted Amino Acid Sequence ◽  
Sequence Analyses ◽  
Als Inhibitors ◽  
Higher Sensitivity

AbstractBarnyardgrass [Echinochloa crus-galli (L.) P. Beauv.] is acknowledged to be the most troublesome weed in rice fields in Anhui and Jiangsu provinces of China. It cannot be effectively controlled using certain acetolactate synthase (ALS)-inhibiting herbicides, including penoxsulam. Echinochloa crus-galli samples with suspected resistance to penoxsulam were collected to identify the target site–based mechanism underlying this resistance. Populations AXXZ-2 and JNRG-2 showed 33- and 7.3-fold resistance to penoxsulam, respectively, compared with the susceptible JLGY-3 population. Cross-resistance to other ALS inhibitors was reported in AXXZ-2 but not in JNRG-2, and occasionally showed higher sensitivity than JLGY-3. In vitro ALS activity assays revealed that penoxsulam concentrations required to inhibit 50% of ALS activity were 11 and 5.2 times greater in AXXZ-2 and JNRG-2, respectively, than in JLGY-3. DNA and predicted amino acid sequence analyses of ALS revealed Ala-205-Val and Ala-122-Gly substitutions in AXXZ-2 and JNRG-2, respectively. Our results indicate that these substitutions in ALS are at least partially responsible for resistance to penoxsulam.

scholarly journals A New NonpolarN-Hydroxy Imidazoline Lead Compound with Improved Activity in a Murine Model of Late-Stage Trypanosoma brucei brucei Infection Is Not Cross-Resistant with Diamidines

2014 ◽  
Vol 59 (2) ◽  
pp. 890-904 ◽  
Author(s):  
Carlos H. Ríos Martínez ◽  
Florence Miller ◽  
Kayathiri Ganeshamoorthy ◽  
Fabienne Glacial ◽  
Marcel Kaiser ◽  
...  
Keyword(s):  
Trypanosoma Brucei ◽  
Late Stage ◽  
Parent Compound ◽  
Central Nervous System Infection ◽  
Sleeping Sickness ◽  
Intrinsic Activity ◽  
Cross Resistance ◽  
Content Type

ABSTRACTTreatment of late-stage sleeping sickness requires drugs that can cross the blood-brain barrier (BBB) to reach the parasites located in the brain. We report here the synthesis and evaluation of four newN-hydroxy and 12 newN-alkoxy derivatives of bisimidazoline leads as potential agents for the treatment of late-stage sleeping sickness. These compounds, which have reduced basicity compared to the parent leads (i.e., are less ionized at physiological pH), were evaluatedin vitroagainstTrypanosoma brucei rhodesienseandin vivoin murine models of first- and second-stage sleeping sickness. Resistance profile, physicochemical parameters,in vitroBBB permeability, and microsomal stability also were determined. TheN-hydroxy imidazoline analogues were the most effectivein vivo, with 4-((1-hydroxy-4,5-dihydro-1H-imidazol-2-yl)amino)-N-(4-((1-hydroxy-4,5-dihydro-1H-imidazol-2-yl)amino)phenyl)benzamide (14d) showing 100% cures in the first-stage disease, while 15d, 16d, and 17d appeared to slightly improve survival. In addition, 14d showed weak activity in the chronic model of central nervous system infection in mice. No evidence of reduction of this compound with hepatic microsomes and mitochondria was foundin vitro, suggesting thatN-hydroxy imidazolines are metabolically stable and have intrinsic activity againstT. brucei. In contrast to its unsubstituted parent compound, the uptake of 14d inT. bruceiwas independent of known drug transporters (i.e.,T. bruceiAT1/P2 and HAPT), indicating a lower predisposition to cross-resistance with other diamidines and arsenical drugs. Hence, theN-hydroxy bisimidazolines (14d in particular) represent a new class of promising antitrypanosomal agents.

Multiple Pro197ALS Substitutions Endow Resistance to ALS Inhibitors within and among Mayweed Chamomile Populations

Weed Science ◽  
2011 ◽  
Vol 59 (3) ◽  
pp. 431-437 ◽  
Author(s):  
Suphannika Intanon ◽  
Alejandro Perez-Jones ◽  
Andrew G. Hulting ◽  
Carol A. Mallory-Smith
Keyword(s):  
Pacific Northwest ◽  
Genotypic Variation ◽  
Point Mutations ◽  
Acetolactate Synthase ◽  
Cross Resistance ◽  
Collection Site ◽  
Whole Plant ◽  
The Pacific ◽  
Als Inhibitors

Mayweed chamomile seeds were collected from six different fields across the Pacific Northwest. All populations (each collection site was considered a population) were suspected to have some level of acetolactate synthase (ALS) resistance. Greenhouse and laboratory studies were conducted to determine if these populations were resistant to three different classes of ALS inhibitors: sulfonylureas (SU), imidazolinones (IMI), and triazolopyrimidines (TP). A whole-plant dose–response andin vitroALS activity studies confirmed cross-resistance to thifensulfuron + tribenuron/chlorsulfuron (SU), imazethapyr (IMI), and cloransulam (TP); however, resistance varied by herbicide class and population. TwoALSisoforms of theALSgene (ALS1andALS2) were identified in mayweed chamomile; however, only mutations inALS1were responsible for resistance. No mutations were found inALS2. Sequence analysis of the partialALSgene identified four point mutations at position 197 (Pro197to Leu, Gln, Thr, or Ser) in the resistant populations. This study demonstrates genotypic variation associated with cross-resistance to ALS inhibitors within and between populations.

Effectiveness of Herbicides for Control of Hairy Vetch (Vicia villosa) in Winter Wheat

2015 ◽  
Vol 29 (3) ◽  
pp. 509-518 ◽  
Author(s):  
William S. Curran ◽  
John M. Wallace ◽  
Steven Mirsky ◽  
Benjamin Crockett
Keyword(s):  
Winter Wheat ◽  
Weed Management ◽  
Acetolactate Synthase ◽  
Oxidase Inhibitor ◽  
Management Program ◽  
Integrated Weed Management ◽  
Hairy Vetch ◽  
Synthetic Auxins ◽  
Als Inhibitors ◽  
Tribenuron Methyl

A field experiment was conducted in 2009–2010 at Pennsylvania and Maryland locations, and repeated it in 2010–2011 to test the effectiveness of POST-applied herbicides at fall and spring timings on seeded hairy vetch in winter wheat. A total of 16 herbicide treatment combinations was tested that included synthetic auxins, acetolactate synthase (ALS) inhibitors, and a protoporphyrinogen oxidase inhibitor. Spring applications tended to be more effective than fall applications. Among synthetic auxins, clopyralid (105 g ae ha−1) and treatments containing dicamba (140 g ae ha−1) were effective at both timings, resulting in greater than 90% hairy vetch control at wheat harvest. Pyroxsulam and prosulfuron applied at 18 g ai ha−1 provided the most effective hairy vetch control (> 90%) at both application timings among ALS inhibitors. Spring applications of several herbicides provided moderate (> 80%) to high (> 90%) levels of hairy vetch control, including: 2,4-D amine (140 g ae ha−1), mesosulfuron-methyl (15 g ai ha−1), tribenuron-methyl (13 g ai ha−1), and thifensulfuron/tribenuron-methyl treatments (16 and 32 g ai ha−1). Winter wheat injury was evaluated, but symptoms were negligible for most treatments. Winter wheat yields declined with increasing hairy vetch biomass. Fall herbicides may be prioritized to reduce hairy vetch competition during the fall and early spring growing season. Our research has established that several synthetic auxin and ALS-inhibiting herbicides, applied POST in fall or spring, can be safely used in winter wheat to control hairy vetch in an integrated weed management program.

scholarly journals Assessment of the In Vivo Activity of SPR741 in Combination with Azithromycin against Multidrug-Resistant Enterobacteriaceae Isolates in the Neutropenic Murine Thigh Infection Model

2018 ◽  
Vol 62 (7) ◽  
Author(s):  
Sean M. Stainton ◽  
Kamilia Abdelraouf ◽  
Luke Utley ◽  
Michael J. Pucci ◽  
Troy Lister ◽  
...  
Keyword(s):  
Potential Role ◽  
Wide Spectrum ◽  
Structural Similarity ◽  
Multidrug Resistant ◽  
Infection Model ◽  
Bacterial Burden ◽  
Content Type ◽  
Novel Agent

ABSTRACT SPR741 is a novel agent with structural similarity to polymyxins that is capable of potentiating the activities of various classes of antibiotics. Previously published studies indicated that although Enterobacteriaceae isolates had minimal susceptibilities to azithromycin (AZM), the in vitro antimicrobial activity of AZM against Enterobacteriaceae was enhanced when it was combined with SPR741. The current study evaluated the in vivo activity of human-simulated regimens (HSR) of AZM equivalent to clinical doses of 500 mg given intravenously (i.v.) every 24 h (q24h) and SPR741 equivalent to clinical doses of 400 mg q8h i.v. (1-h infusion), alone and in combination, against multidrug-resistant (MDR) Enterobacteriaceae . We studied 30 MDR Enterobacteriaceae isolates expressing a wide spectrum of β-lactamases (ESBL, NDM, VIM, and KPC), including a subset of isolates positive for genes conferring macrolide resistance ( mphA , mphE , ermB , and msr ). In vivo activity was assessed as the change in log 10 CFU per thigh at 24 h compared with 0 h. Treatment with AZM alone was associated with net growth of 2.60 ± 0.83 log 10 CFU/thigh. Among isolates with AZM MICs of ≤16 mg/liter, treatment with AZM-SPR741was associated with an average reduction in bacterial burden of −0.53 ± 0.82 log 10 CFU/thigh, and stasis to 1-log kill was observed in 9/11 isolates (81.8%). Combination therapy with an AZM-SPR741 HSR showed promising in vivo activity against MDR Enterobacteriaceae isolates with AZM MICs of ≤16 mg/liter, including those producing a variety of β-lactamases. These data support a potential role for AZM-SPR741 in the treatment of infections due to MDR Enterobacteriaceae .

scholarly journals The occurrence of herbicide-resistant Avena fatua (wild oats) populations to ACCase-inhibiting herbicides in Ireland

2021 ◽  
Author(s):  
R. Byrne ◽  
A.V. Vijaya Bhaskar ◽  
J. Spink ◽  
R. Freckleton ◽  
P. Neve ◽  
...  
Keyword(s):  
Herbicide Resistance ◽  
Weed Management ◽  
Resistance Mechanism ◽  
Point Mutations ◽  
Acetolactate Synthase ◽  
Avena Fatua ◽  
Integrated Weed Management ◽  
Cross Resistance ◽  
Wild Oats ◽  
Als Inhibitor

Following growers’ reports of herbicide control problems, populations of 30 wild oats, Avena fatua, were collected from the south-east main arable counties of Ireland in 2016 and investigated for the occurrence and potential for herbicide resistance to acetyl-CoA carboxylase (ACCase) inhibitors pinoxaden, propaquizafop and cycloxydim, as well as acetolactate synthase (ALS) inhibitor mesosulfuron + iodosulfuron. Plant survival ≥20% was considered as the discriminating threshold between resistant and susceptible populations, when plants were treated with full recommended field rates of ACCase/ALS inhibitors. Glasshouse sensitivity screens revealed 2 out of 30 populations were cross-resistant to all three ACCase inhibitors. While three populations were cross-resistant to both pinoxaden and propaquizafop, and additionally, two populations were resistant to propaquizafop only. Different degree of resistance and cross-resistance between resistant populations suggest the involvement of either different point mutations or more than one resistance mechanism. Nevertheless, all populations including the seven ACCase-resistant populations were equally susceptible to ALS inhibitor. An integrated weed management (cultural/non-chemical control tactics and judicious use of herbicides) approach is strongly recommended to minimize the risk of herbicide resistance evolution.

scholarly journals Menoctone Resistance in Malaria Parasites Is Conferred by M133I Mutations in Cytochrome b That Are Transmissible through Mosquitoes

2017 ◽  
Vol 61 (8) ◽  
Author(s):  
Lynn D. Blake ◽  
Myles E. Johnson ◽  
Sasha V. Siegel ◽  
Adonis McQueen ◽  
Iredia D. Iyamu ◽  
...  
Keyword(s):  
Inhibitory Concentration ◽  
Synthesis Method ◽  
Cross Resistance ◽  
Liver Stage ◽  
Content Type ◽  
Transmission Potential ◽  
The Past ◽  
Related Mortality

ABSTRACT Malaria-related mortality has slowly decreased over the past decade; however, eradication of malaria requires the development of new antimalarial chemotherapies that target liver stages of the parasite and combat the emergence of drug resistance. The diminishing arsenal of anti-liver-stage compounds sparked our interest in reviving the old and previously abandoned compound menoctone. In support of these studies, we developed a new convergent synthesis method that was facile, required fewer steps, produced better yields, and utilized less expensive reagents than the previously published method. Menoctone proved to be highly potent against liver stages of Plasmodium berghei (50 percent inhibitory concentration [IC50] = 0.41 nM) and erythrocytic stages of Plasmodium falciparum (113 nM). We selected for resistance to menoctone and found M133I mutations in cytochrome b of both P. falciparum and P. berghei. The same mutation has been observed previously in atovaquone resistance, and we confirmed cross-resistance between menoctone and atovaquone in vitro (for P. falciparum) and in vivo (for P. berghei). Finally, we assessed the transmission potential of menoctone-resistant P. berghei and found that the M133I mutant parasites were readily transmitted from mouse to mosquitoes and back to mice. In each step, the M133I mutation in cytochrome b, inducing menoctone resistance, was confirmed. In summary, this study is the first to show the mechanism of resistance to menoctone and that menoctone and atovaquone resistance is transmissible through mosquitoes.

scholarly journals Click Chemistry-Facilitated Structural Diversification of Nitrothiazoles, Nitrofurans, and Nitropyrroles Enhances Antimicrobial Activity against Giardia lamblia

2017 ◽  
Vol 61 (6) ◽  
Author(s):  
Wan Jung Kim ◽  
Keith A. Korthals ◽  
Suhua Li ◽  
Christine Le ◽  
Jarosław Kalisiak ◽  
...  
Keyword(s):  
Click Chemistry ◽  
Giardia Lamblia ◽  
Diarrheal Disease ◽  
Wide Spectrum ◽  
Fold Increase ◽  
Side Chain ◽  
Full Potential ◽  
Content Type

ABSTRACT Giardia lamblia is an important and ubiquitous cause of diarrheal disease. The primary agents in the treatment of giardiasis are nitroheterocyclic drugs, particularly the imidazoles metronidazole and tinidazole and the thiazole nitazoxanide. Although these drugs are generally effective, treatment failures occur in up to 20% of cases, and resistance has been demonstrated in vivo and in vitro. Prior work had suggested that side chain modifications of the imidazole core can lead to new effective 5-nitroimidazole drugs that can combat nitro drug resistance, but the full potential of nitroheterocycles other than imidazole to yield effective new antigiardial agents has not been explored. Here, we generated derivatives of two clinically utilized nitroheterocycles, nitrothiazole and nitrofuran, as well as a third heterocycle, nitropyrrole, which is related to nitroimidazole but has not been systematically investigated as an antimicrobial drug scaffold. Click chemistry was employed to synthesize 442 novel nitroheterocyclic compounds with extensive side chain modifications. Screening of this library against representative G. lamblia strains showed a wide spectrum of in vitro activities, with many of the compounds exhibiting superior activity relative to reference drugs and several showing >100-fold increase in potency and the ability to overcome existing forms of metronidazole resistance. The majority of new compounds displayed no cytotoxicity against human cells, and several compounds were orally active against murine giardiasis in vivo. These findings provide additional impetus for the systematic development of nitroheterocyclic compounds with nonimidazole cores as alternative and improved agents for the treatment of giardiasis and potentially other infectious agents.

Sign in / Sign up

Export Citation Format

Share Document